INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 54 filers reported holding INOZYME PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,330 | +18.2% | 53,888 | +56.7% | 0.00% | – |
| Q2 2023 | $191,547 | +1429.9% | 34,389 | +188.4% | 0.00% | – |
| Q4 2022 | $12,520 | -79.1% | 11,924 | -4.6% | 0.00% | – |
| Q2 2022 | $60,000 | +11.1% | 12,505 | -5.7% | 0.00% | – |
| Q1 2022 | $54,000 | -40.0% | 13,255 | +0.1% | 0.00% | – |
| Q4 2021 | $90,000 | -53.1% | 13,239 | -20.1% | 0.00% | – |
| Q3 2021 | $192,000 | -41.6% | 16,565 | -14.2% | 0.00% | – |
| Q2 2021 | $329,000 | -30.1% | 19,310 | -18.8% | 0.00% | – |
| Q1 2021 | $471,000 | +9.5% | 23,790 | +14.2% | 0.00% | – |
| Q4 2020 | $430,000 | +19.4% | 20,839 | +52.3% | 0.00% | – |
| Q3 2020 | $360,000 | – | 13,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,009,117 | $26,529,000 | 9.44% |
| YALE UNIVERSITY | 113,502 | $2,984,000 | 9.13% |
| Sofinnova Investments, Inc. | 2,028,308 | $53,324,000 | 3.95% |
| Novo Holdings A/S | 2,569,379 | $67,549,000 | 3.35% |
| NEA Management Company, LLC | 2,444,379 | $64,263,000 | 2.72% |
| RA Capital Management | 2,003,653 | $52,676,000 | 0.96% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,150,299 | $30,241,000 | 0.74% |
| Rock Springs Capital Management LP | 879,954 | $23,134,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 196,411 | $5,164,000 | 0.51% |
| Orbimed Advisors | 400,400 | $10,527,000 | 0.13% |